ANNEX PUBLISHERS

Clinical and Experimental Research in Cardiology

ISSN: 2394-6504

Open Access
Research Article
Max Screen >>

Study of Enzymes in Myocardial Infarction

Received Date:April 28, 2018 Accepted Date: June 20, 2018Published Date: June 22, 2018

Copyright: © 2018 Sudha Rani Yeluri. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Related article at Pubmed, Google Scholar

Introduction

The term Myocardial infarction signifies sudden necrosis or death of a portion of cardiac muscle due to inadequate blood supply [1]. Myocardial infarction results from prolonged myocardial coronary thrombus at the site of a pre-existing atherosclerotic stenosis [2]. The major cause of acute myocardial infarction is atherosclerosis [3]. It is three to four times more frequent among men than women [4].

The term Myocardial infarction signifies sudden necrosis or death of a portion of cardiac muscle due to inadequate blood supply [1]. Myocardial infarction results from prolonged myocardial coronary thrombus at the site of a pre-existing atherosclerotic stenosis [2]. The major cause of acute myocardial infarction is atherosclerosis [3]. It is three to four times more frequent among men than women [4].

Ischaemic Heart Disease

Ischaemic heart disease is defined by the “World Health Organization” (WHO, 1979) as myocardial impairment due to imbalance between the supply and demand of the heart for oxygenated blood. The term IHD is synonymous with the term Coronary artery disease (CAD) or coronary heart disease (CHD) [8].

Coronary artery disease represents a spectrum of conditions with acute transmural infarction at one end of the spectrum, ranging successively through non transmural infarction, Unstable Angina and chronic stable angina to silent ischaemia at other end [9].

Myocardial Infarction

Myocardial infarction is either a) acute myocardial infarction b) chronic myocardial infarction.

Complications of myocardial infarction are,
1. Sudden death, 2. Uncomplicated cases, and 3. Complicated cases

Complications associated with myocardial infarction are,
a) Cardiac arrhythmias, b) Left ventricle congestive failure, c) Cardiogenic shock and d) Thromboembolism

Sudden Cardiac Death: Most commonly sudden cardiac death is defined as unexpected death from cardiac causes within one hour of the onset of acute symptoms [10].

Coronary artery disease is posing a major health challenge in India. Prevalence of coronary artery disease in India is 10/1000 to 126/1000. In Indians coronary artery disease (CAD) commonly manifests as acute myocardial infarction without prior angina. By 2015AD, coronary artery disease will account for 34% of all male deaths and 32% of all female deaths in India Lifestyle changes related to diet, mechanization, increased sedentary outlook, increase in serum cholesterol, hypertension, insulin resistance, obesity and dyslipidemia are responsible for this increase (Table 1). Asian Indians have the highest rates of mortality from coronary artery disease amongst all ethnic groups studied so far and the coronary artery disease in them is often premature and follows a malignant course [11].

It has become necessary to achieve early diagnosis the causes of myocardial infarction, to assess the effectiveness of treatment, and to predict prognosis. So serial estimations of plasma enzymes in course of myocardial infarction are of greatest value in diagnosing and predicting the prognosis in these patients [12,13].

In conclusion myocardial infarction is a major public health problem and the need remains to prevent myocardial infarction by avoiding the modifiable risk factors [14].

The present study is carried out to compare the enzymes (Total creatine kinase, creatine kinase MB, total lactate dehydrogenase, lactate dehydrogenase-1, lactate dehydrogenase-2 and aspartate-aminotransferase) in myocardial infarction with normal subjects (Table 2) [12].

The enzyme study in myocardial infarction is done by a number of research workers. My aim is to study the enzymes so as to correlate my findings with earlier findings (Table 3).

Aim of Study

The present study is done in patients suffering from acute Myocardial infarction [15].

Aim of this study is to assess the effectiveness of therapy in patients of acute myocardial infarction with the help of serial estimation of enzyme levels of,
1. Total creatine kinase.
2. Creatine kinase MB.
3. Total lactate dehydrogenase.,
4. Lactate dehydrogenase isoenzyme LDH-1 and LDH-2.
5. Aspartate aminotransferase.
6. Lipid profile is done to evaluate risk factors (Table 2).

It is always better to detect the acute Myocardial infarction in very early stage by suitable cardiac markers, for better prevention and for management of complications.

Review of Literature
Atherosclerosis

Atherosclerosis has been recognized in humans for thousands of years. Lesions of atherosclerosis were identified in Egyptian mummies as early as the 15th century B. C. Long has discussed the development of clinicopathological correlation between the degree of atherosclerosis and the incidence of myocardial infarction [16].

Early proposal was made by Virchow, Von Rokitansky and Duguid. Virchow believed that a form of low-grade injury to the arterial wall resulted in a type of inflammatory insulation which in turn caused increased passage and accumulation of plaque constituents in the intima of artery. Rokitansky’s belief subsequently elaborated upon by Duguid and was that an encrustation of small mural thrombi existed at the sites of coronary artery injury. These thrombi organized by the growth of smooth muscle cells into them and that they would become incorporated into the lesion and thus serve as sites where the lesions would progress [17].

In 1973 these two studies about atherogenesis were combined with new knowledge of the cellular and molecular biology of the arterial wall in a hypothesis termed The Response to Injury Hypothesis of atherosclerosis. A second hypothesis that was also formulated in 1973 was the Monoclonal Hypothesis which suggests that the lesion of atherosclerosis may represent some form of neoplasia [18].

Gross Pathological Changes: On gross inspection acute MI can be divided into two major types.
1. Transmural infarcts also called as Q wave infarct; in which myocardial necrosis involve the full thickness of the ventricular wall [19].
2. Subendocardial infarct also called as non Q wave infarct, in which the necrosis involves the subendocardium without extending all the way through the ventricular wall in to the epicardium.

An occlusive coronary thrombosis appears to be far more common when the infarct is transmural and localized to the distribution of a single coronary artery. Non transmural infarct frequently occur in the presence of severely narrowed but still patent coronary arteries [20].

Gross alteration of the myocardium is difficult to identify until at least 6-12 hours has elapsed following the onset of necrosis. Tissue slices of suspected infarct site are immersed in a solution of Triphenyltetrazolium chloride, which stains viable myocardium brick-red and leaves the infarcted region pale as a result of failure of uptake of vital dye by the infarct [21].

The Pathogenesis of Atherosclerosis: The term atherosclerosis is derived from Greek Athero (gruel or porridge) and Sclerosis (Hardness).

Atherosclerosis is a multifactorial process and is a principle cause of death in western civilization. It is a progressive disease process that generally begins in childhood and has clinical manifestations in middle to late adult hood. Atherosclerosis was considered to be a degenerative process because of accumulation of lipids and necrotic debris in the advanced lesions [22].

Disease of coronary artery is almost always due to atheroma and its complications particularly thrombosis. Atheroma or Atherosclerosis is patchy focal diseases of the arterial intima especially the coronary arteries which are at high risk [23].

In western countries atheromatous plagues begin to appear in the 2nd and 3rd decade of life. The earliest lesion of atherosclerosis can be found in young children and infants in the form of a lesion called the Fatty streak whereas the advanced lesion is called the fibrous plaque. Chau (2009) observed the fatty streak which consists principally of lipid-laden macrophages. It appears as an area of yellow discoloration due to large amount of lipid deposited in the foam cells.

Fatty streaks develop and circulating monocytes migrate into the tunica intima, take up oxidized low density lipoprotein (LDL) from the plasma and become lipid-laden foam cells [24]. Smooth muscle cells then migrate into and proliferate within plaque. As the lesion grows it encroaches into the lumen of the vessel and erodes the tunica media.

A mature fibrolipid plaque has a core of extracellular lipid, surrounded by smooth muscle cells and is separated from the lumen by a thick cap of collagen rich fibrous tissue. Such plaque may rupture or fissure, allowing blood to enter and compromise the lumen of the vessel and often precipitates thrombosis and local vasospasm [25].

Blood Supply of Myocardium

Myocardium is supplied by a pair of coronary arteries namely the right coronary artery and the left coronary artery. They originate at the root of aorta from the sinuses of valsalva.

Left Coronary Artery

Left coronary artery divides into two branches:
a) Anterior descending branch
b) Circumflex branch.

It supplies major part of left atrium and left ventricular and septum between them.

Right Coronary Artery

It supplies Right atrium, interventricular septum, and both ventricles [26].

Normal Coronary Blood Flow

Resting coronary blood flow in human is approximately 225ml /min., which is about 4-5% of blood flow through coronary system [26].

Special Features of Cardiac Muscle Metabolism

Under resting conditions, cardiac muscle mainly uses fatty acid for its energy. About 70% of its normal metabolism is derived from fatty acids but under anaerobic conditions i.e. during ischaemia cardiac muscle undergoes anaerobic glycolysis for energy, producing lactic acid. In cardiac tissue accumulation of lactic acid is one of the causes of cardiac pain in ischaemic conditions. In severe ischaemia ATP in myocardial cells degrades to ADP and inorganic phosphate and ADP is further degraded to adenosine. Myocardial cell membrane is permeable to adenosine, and this causes vasodilatation of coronary arterioles during hypoxia. This adenosine may be replaced in myocardium only at the rate of two percent per hour. Hence after a serious bout of ischaemia for about a half an hour, relief of coronary ischaemia is too late, to save myocardial cells from damage leading to cellular necrosis [27].

Effect of Hypoxia on Myocardial Cells

When oxygen supply to the cell is reduced or impaired, the cell rapidly depletes its store of phosphocreatine and glycogen. ATP production falls below the level required by membrane ion pump for the maintenance of proper intracellular ionic concentrations. Due to this, osmotic balance is disrupted and cell and its membrane-enveloped organelles begin to swell. This results in over stretching of membranes leading to leak-age of cell contents chiefly enzymes. Decreased intracellular pH in anaerobic glycolysis, releases lysosomal enzymes. This lysosomal enzymes at this low pH cause cell damage. Rapidly respiring tissue like heart and brain are more prone to such damage [28,29].

Adenosine

Adenosine monophosphate (AMP) is produced whenever the myocardial capacity to produce ATP is decreased and utilization of ATP is increased. The enzyme 5’ Nucleotidase is responsible for the formation of adenosine from AMP. Adenosine is a powerful vasodilator [26].

Endothelial Dysfunction & Myocardial Ischaemia

Endothelial vasodilator dysfunction has been implicated in the pathogenesis of coronary constriction, which is triggered by thrombosis, and the products of platelet aggregation. Lipid abnormalities, smoking, hypertension and advanced age, all of them can be associated with endothelial dysfunction [30].

In generated Eskimos the incidence of coronary heart disease is very low because they consume large amount of fish rich in Eicosapentaenoic fatty acid which decreases thromboxane there by increases prostacyclin level. This PGI2 has antiplatelet aggregation effect [31].

Effects of Ischaemia in Myocardial Metabolism High Energy Phosphate Metabolism

During the first few minutes of severe ischaemia, the production of high-energy phosphates (the sum of ATP and creatine phosphate) declines and its utilization exceeds. The combination of reduced myocardial high energy-phosphate stores, cell swelling and sarcolemmal damage appears to play a key role in cell death with ischaemia (or) reperfusion [32].

Risk factors for the Development of Atherosclerosis & Myocardial Infarction

By risk factor it is meant, that a characteristic, which is associated with a greater than average probability, of developing coronary heart disease.

Important Risk Factors for Coronary Artery Disease

Sex:Perhaps one of the best-documented risk factors for atherosclerosis is the male sex. In India, incidence of coronary artery disease in males is more common than western countries. It has been suggested that females have a decreased incidence because of protective function exerted by estrogens. Hormonal replacement therapy (HRT) reduces the risk of ischaemic heart disease in postmenopausal women [33].

Age: The incidence of Coronary artery disease increases with age. The incidence is highest in the sixth decade in Western countries. In India as per the epidemiological survey the incidence is at least a decade earlier than western countries [34].

Family History: A family history of coronary artery disease has been shown to be a strong independent risk factor for coronary artery disease.

Hyperlipidemia: In men and women between the ages of 35-44 years the serum cholesterol levels of 265 mg/100ml or more is associated with four times at higher risk of developing coronary artery disease than the levels below 220 mg/100ml of blood. Dietary saturated fatty acid elevates serum cholesterol whereas polyunsaturated fatty acid rich diet lowers the plasma cholesterol level by 10 to 20%. There is a positive correlation between risk of developing ischaemic heart disease and plasma low density lipoprotein cholesterol levels [35,36]. It has been established that lowering the high-levels of low density lipoprotein cholesterol (LDL-C) in plasma reduces the risk of ischaemic heart disease. High plasma high density lipoprotein cholesterol (HDL-C) probably by facilitating the clearance of cholesterol from arterial smooth muscle cells and transporting it in to liver (scavenging action) reduces the risk of ischaemic heart disease [30,36] (Table 4).

Hypertension: Elevated blood pressure is directly associated with atherosclerosis and increased risk of ischaemic heart disease. With blood pressure exceeding 160/95, the incidence of ischaemic heart disease is five times more common than that of normotensive individuals [37]. Diastolic pressure is more correlated with risk than systolic pressure. If diastolic pressure is more than 105mmHg, risk of developing ischaemic heart disease is four times more when compared with individuals having diastolic pressure of 84 mmHg or less. Hypertension if associated with other risk factors like hyperlipidemia and diabetes mellitus the individual is at higher risk of developing ischemic heart disease [38,39].

Clinical Diabetes Mellitus

A diabetic individual is two time at higher risk of developing ischaemic heart disease when compared with no-diabetic person. Insulin resistance associated with obesity, is a potent risk factor for chronic coronary heart disease. Risk is markedly increased in young diabetics. Diabetic women are more prone to ischemic heart disease than diabetic men [40,41].

Smoking

Tobacco is probably the most important avoidable cause of coronary heart disease. Epidemiological studies have firmly established that cigarette smoking independently predisposes to myocardial infarction. Framingham study showed that cardiovascular mortality increased by 18% in men and 3% in females for each 10 cigarettes smoked per day. It is both an independent risk factors for ischaemic heart disease and also interacts additively with other factors like hypertension, hyderlipidemia, and diabetic mellitus. Smoking leads to premature and more severe form of chronic disease. It is likely to develop ischaemic heart disease at younger age group. Smoking lowers, high density lipoprotein levels in males by 12% and in females by 7% [42].

Cigarette smoking is associated with high levels of carboxyhemoglobin and low oxygen delivery to tissue leading to hypoxia. Hypoxia could produce diminished lysosomal enzyme degradative ability as evidenced by impaired degradation of low density lipoprotein (LDL) by smooth muscle cells causing low density lipoprotein to accumulation in muscle cells leading to atherogenesis [43].

Obesity

Obesity predisposed to premature chronic heart disease. In the Framingham Heart study, obesity was found to be independent risk factor for cardiovascular disease in both men and women. Greater the weight, the greater is the risk particularly in younger age group. Obese individuals have higher incidence of hyperlipidemia, hyper-tension and diabetes mellitus leading to higher incidence of ischaemic heart disease [44-46].

Alcohol

Consumption of alcohol seemed to offer some protection against coronary heart disease. However heavy alcohol consumption is associated with hypertension and increased serum cholesterol levels.

Physical Activity

Regular exercise appears to have a protective effect from coronary heart disease, by increasing the levels of high density lipoprotein levels. In sedentary individual risk of ischemic heart disease is about three times higher when compared with individual who is physically active. Physically active people have elevated levels of serum high density lipoprotein cholesterol (HDL-C) levels, which probably have beneficial effect [ 47].

So, HDL cholesterol is called antiatherogenic, good cholesterol and high HDL-C is having a protective role against coronary heart disease.

Oral Contraceptive Drugs

Oral contraceptive drugs may increase coronary heart disease risk.by increasing BP and by thrombogenic action.

Psychosocial Factors

Type A personalities are more prone to coronary heart disease. Coronary artery disease is of greater prevalence in upper and middle socioeconomic classes [48].

Triacyglycerol (TAG)

Pais prospective study was suggested triacylglycerol is an important risk factor. Mean triacylglycerol levels of Indians with coronary artery disease are 20-40mg/dl, lower than in Caucasians with coronary artery disease [49].

HDL-C

It is frequently called good cholesterol. Inverse relationship existed between plasma HDL-C and coronary artery disease. HDL-C levels are low in Indians with coronary artery disease. TC / HDL-C (>4.5) is considered to be the most powerful predictor of coronary artery disease. Low optimal HDL level is >35 mg/dl. NCEP defines 3 categories of HDL-C as
A) Normal HDL (35-60mg/dl) [50].
B) Low HDL (<35 mg/ dl),
C) High HDL (>60 mg/dl)

LDL-C

High small dense LDL-C has been found to be more specific risk factor of coronary artery disease than LDL-C. It carries three fold greater risk of coronary artery disease irrespective of LDL-C level. So, LDL cholesterol is often called as bad cholesterol [51].

Lipoprotein(a)

It is a low density lipoprotein like particle which has an apolipoprotein (a). It has close homology with plasminogen. Its measurements are best made in patients, when conventional risk factors are unable to help deter-mine coronary risk. Its level in patients with coronary artery disease are twice those of controls. It influences basal thrombogenic activity on endothelium [ 52].

Serum Fibrinogen

Fibrinogen is a major determinant of plasma viscosity and coronary artery disease risk. Frequent donation of blood, has protection against acute myocardial infarction, because it reduces blood viscosity [53].

Thrombogenic Factors

Asian Indians are known to have elevated levels of Lipoprotein (a), homocysteine, tissue plasminogen factor, Plaminogen activator factor.

Homocysteinemia

Increased plasma concentration of homocysteine doubles the risk of coronary artery disease. Excess homocysteine can form homocysteine thiolactone, a reactive intermediate which thiolate free amino acid in LDL and cause them to aggregate [54].

Normal Lipprotein Meabolism

Structure and Composition: Lipoproteins are conjugated proteins and they are molecular complexes that consists of lipids and proteins. “Lipoproteins” serve as carriers of lipids in plasma as lipids are insoluble in water. The hydrophobic cholesteryl ester and triacylglycerol form the neutral lipid core which is covered by a coat shell of amphipathic lipids like phospholipids and free cholesterol layer. This layer is interspersed by the apoproteins to make them water miscible hydrophilic complex lipoproteins [55,56].

Classification of Lipoproteins

There are 3 types of classifications,
1. By Ultracentrifugation: Lipoproteins are classified by ultracentrifugation, based on, the density of lipoproteins into Chylomicrons (least dense, so float on the top of test tube), followed by VLDL, IDL, LDL and HDL (at the bottom) [57].
2. By Electrophoresis: By the migration of charged particles in electric field the lipoproteins are separated. Chylomicrons remain at the origin, followed by beta lipoproteins, then pre-beta lipoproteins and at the anode alpha lipoproteins, pre beta LP=VLDL, beta LP=LDL, alpha LP=HDL [ 58].
3. By apoprotein moiety: Apo B48 --- Chylomicrons, Apo B 100 --- VLDL, LDL and Apo A ---HDL.

Chylomicrons

Chylomicrons are synthesized in the intestine. They are the vehicles for the transport of exogenous triacylglycerol. Chylomicron is the largest lipoproteins in size and is the least dense. The main apoprotein in chylomicron is Apo-B48. The enzyme lipoprotein lipase located at the endothelial layer of capillaries is activated by apoC-II and released from endothelium of capillaries in to the blood stream by heparin. Lipoprotein – lipase hydrolyses the triacylglycerol present in the chylomicrons in to fatty acids and glycerol. Chylomicrons are converted to chylomicron remnants by the action of lipoprotein lipase and this chylomicron remnants have half the size of chylomicrons and are rich in cholesterol and Apo E [59].

Very Low Density Lipoproteins (VLDL)

These lipoproteins are the vehicle for the transport of endogenous triacylglycerol, from liver to extrahepatic tissues. VLDL is rich in triacylglycerol. They are synthesized in the liver from glycerol and fatty acids & incorporated into VLDL along with hepatic cholesterol apo-B-100, ApoC & ApoE. They pass through the space of Disse and then into hepatic sinusoids through fenestrae in the endothelial lining. When VLDL reach the peripheral tissue they are hydrolyzed by lipoprotein lipase to IDL (intermediate density lipoproteins), and, IDL is hydrolysed to LDL. The VLDL secreted into blood stream gains more apoC from HDL [60].

Intermediate Density Lipoproteins (IDL)

After hydrolysis of VLDL, short lived IDL, are formed which are partly depleted of triacylglycerol. IDL are further hydrolyzed into LDL.

Low Density Lipoproteins (LDL)

These are the major cholesterol carrying components of plasma.
Apo-B 100 is the major protein present in LDL & comprises 25% of LDL mass. LDL’s are mainly formed from VLDL breakdown.

High Density Lipoproteins (HDL)

HDL is synthesized from liver and intestine. Nascent HDL is discoid in shape. Lecithin cholesterol acyl transferase (LCAT) converts free cholesterol and phospholipid to cholesterol ester and lysolecithin. Apo A1 is the cofactor for LCAT. Non-polar cholesterol - ester moves into hydrophobic interior of discoidal and HDL becomes spherical. HDL functions to transport cholesterol from tissues to liver, a process known as reverse cholesterol transport. This process of scavenging action of cholesterol is the main function of HDL. HDL concentration is negatively related to the incidence of coronary atherosclerosis. HDL is rich in phospholipid. These are three well defined HDL sub groups viz.HDL1.HDL2 and HDL3. The major apolipoproteins found in HDL are apo A-II, which constitutes about 90% of total HDL protein [61] (Table 5).

Lipoprotein Metabolism
Exogeneous Pathway

Enterocytes absorb dietary cholesterol & triacylglycerols from the gut in the form of free cholesterol, fatty acids and monocylglycerols. After re-esterification, cholesteryl esters & triacylglycerols are incorporated into the core of chylomicron particles. Enterocytes synthesize apo B-48, apo A-I & apo A-IV which together with phospholipids, from the surface layer of the chylomicrons particles. Apo B-48 is essential for chylomicron secretion [62].

The newly secreted chylomicrons pass into the intestinal lymph and gain access to the vascular system via the thoracic duct.

Endogenous Pathway

The hepatocyte is the originator and often also the acceptor of Particles involved in the endogenous pathway. The liver secretes VLDL, a triacylglycerol rich lipoprotein

LDL accounts for 70% or more of the total plasma cholesterol. The major determinant of plasma LDL concentration is the number of functional LDL receptors. The LDL receptor recognizes both apo B-100 on LDL and apo-E on remnant particles of HDL. Once the lipoprotein has been bound to the receptor, the receptor - lipoprotein complex localizes in the coated pit region from where it is internalized by endocytosis. The LDL receptor is recycled whilst the lipoprotein undergoes lysosomal degradation to un-esterified cholesterol and amino acids.

Myocardial infarction is said to be present if a patient exhibits two of the following three abnormalities.
1. Chest pain typical of Myocardial infarction.
2. ECG changes.
3. Elevation of Cardiac enzymes (Hurt, 1978), (the cardiac markers.)

E.C.G. Changes: 1. The earliest ECG changes are usually ST elevation. In transmural infarction Q wave begins to develop, finally T wave inversion are seen.
2. In subendocardial infarction T wave inversion without Q wave or ST elevation is noted.

Chest Pain: Retrosternal pain is the cardinal symptom of myocardial infarction, but breathlessness, sweating, vomiting and collapse or syncope are common features. Pain is more severe and lasts longer, typically present as tight-ness, heaviness or constricting in nature in the chest. Painless or silent myocardial infarction is common in elderly and diabetic patients.

Enzyme Study

Alteration in the cell permeability or necrosis or injury to tissues results in the escape of intracellular enzymes into the circulation. The measurement of these released enzymes in peripheral venous blood represents one of the sensitive techniques for detecting myocardial necrosis. The time course of depletion of an enzyme from damaged organ parallels the time course of increased activity of same enzyme in serum [63]. The serum levels of the cardiac markers i.e. CK, LDH and AST are commonly determined in the diagnosis of acute myocardial infarction (see Table 6). Isoenzymes of CK, LDH are more specific in clenching the diagnosis of myocardial infarction [64].

Enzymes
Creative Kinase (E.C.2.7.3.2)

It was formerly called as Creatine Phosphokinase (CPK).

Its systemic name is Adenosine triphosphate, creatine phosphotransferase (CK). Phosphocreatine is the most important storage form of high energy phosphate in muscles. The enzyme creatine kinase catalyses the reversible phosphorylation of creatine by ATP. Optimum pH for forward reaction is 9 and for backward reaction are 6.7. Hence equilibrium position for this reaction is dependent on pH. At neutral pH creatine phosphate has a much higher phosphorylating potential than ATP and this favours the reverse reaction i.e. formation of ATP from creatine phosphate by transferring high energy phosphate group to ADP to form ATP using creatine phosphate as phosphate donor. This reaction is called “Lohmann’s” reaction [65].

The reverse reaction proceeds two to six times faster-than the forward reaction, depending on the reaction conditions. Magnesium is an obligate activating ion to form ADP and ATP- Mg complex. The enzyme CK in serum is unstable. Activity is restored by N-acetyl cysteine. When muscle contracts ATP is consumed and CK catalyses the re-phosphorylation of ADP to form ATP using creatine phosphate as the phosphorylation reservoir [66].

Creatine kinase is a dimer composed of two polypeptides, consisting of two subunits each with a molecular weight of about 40,000. These subunits are named as B for brain, M for muscle. CK exists in three different pairs of subunits forming three isoenzymes[67].(a) BB-CK-1 (b) MB-CK-2 (c) MM-CK-3. Out of these three isoenzymes, CKMB is predominant in myocardium and the elevated CKMB levels are more specific for the diagnosis of myocardial infarction [68]. Each of CK isoenzymes shows a characteristic electrophoretic mobility. Increase in CK level excludes liver disease. Isoenzyme originating from muscle is far more in quantity. So, detection of CKMB isoenzyme is important in the diagnosis of myocardial infarction. CKMB is 15-24% of the total CK in myocardial infarction.

% relative index === CKMB mass * 100 total CK activity

% Relative index aids in the interpretation of CKMB concentration for the detection of acute myocardial infarction and in differentiating cardiac enzyme release from skeletal muscle release.

Normal value of CKMB is 0-5U/L.

Clinical significance: Following myocardial infarction CKMB activity rises along with total CK activity. CKMB activity begins to rise within 4 to 6 hours and reaches peak by 12 to 24 hours after onset of chest pain and reaches normal level by 48 hours [69]. The peak level of activity depends on size and extent of infarction. Therefore, CK estimation is very useful and sensitive indicator to detect early cases where ECG changes are ambiguous.

Other Conditions Causing Elevation of Creatine Kinase Activity in Serum: The level of CK is very much elevated in all types of muscular dystrophies especially Duchenne’s type. CPK is elevated in crush injury, in intramuscular injection, hypothyroidism, delirium tremors, in women following delivery, after severe exercise, seizures, polymyositis, malignant hyperthermia, acute rhabdomyolysis, and paroxysmal myoglobinuria (Table 7). Hence diagnosis of myocardial infarction should be based on both clinical findings and biochemical parameters. The CK levels are not increased in hemolysis or in congestive cardiac failure and therefore CK has an advance over LDH.

Lactate Dehydrogenase (e.c.1.1.127): LDH is the enzyme of glycolysis. Its systemic name is L-Lactate-NAD+ Oxidoreductase (LDH). LDH (Zinc-protein complexes) is a hydrogen transfer enzyme which catalyses the oxidation of L – Lactate to Pyruvate with mediation of NAD+ as hydrogen acceptor. LDH playing an important part in anaerobic glycolysis. This is a reversible reaction and reaction equilibrium strongly favours reverse reaction viz. The reduction of Pyruvate to lactate. Enzyme is located in the cytoplasm [70].

LDH does not act on D-lactate. The equilibrium is such that the backward reaction above is more than twice as fast as forward and most workers have used Pyruvate as substrate. Lactate has the advantage of being more stable than Pyruvate and NAD+ is cheaper than NADH. At pH7 the equilibrium of reaction is to the right. At pH 8 or 9 reverse reaction occurs i.e. from right to left.

Lactate dehydrogenase enzyme LDH is a tetramer and has a molecular weight of 1,34,000 and is composed of four poly-peptide chains and is composed of two different type M and H subunit (MW of each is about 34,000) [71]. Only the tetrameric molecule possesses the catalytic activity. In the order of decreasing anodal mobility in alkaline medium (in electrophoresis), are LDH1, LDH2, LDH3, LDH4 and LDH5 (Table 8). Moving fastest towards the anode is designated as LDH-1. Slowest moving isoenzyme is called LDH-5. Hence these protomers combine in the following ways to form five isoenzymes.

LDH-1 moves just behind the tearing edge of the albumin fraction. LDH-5 migrates with the gammaglobulin. The difference in electrophoretic mobility is due to different electric charges on the isoenzyme produced by the difference in the contents of acidic and basic aminoacids. The isoenzymes have different pH optima and Km value. Km for LDH-1 is high. Km for LDH-5 is low. Normally LDH-1 is 16-28% of total LDH. LDH-2 is 29-37% of total LDH LDH > 1500 U/L is associated with grave prognosis.

Distribution of Isoenzymes in Human Tissue: LDH is not a tissue specific enzyme. LDH-1, LDH-2 are predominant in myocardium, erythrocyte, Kidney. LDH-4, LDH-5 are predominant in liver and skeletal muscle. LDH-3, LDH-4 are present in lung, spleen, and endocrine glands, and lymph nodes [72]. LDH-1 and LDH-2 are predominant after myocardial infarction. LDH- 4 and LDH-5 are predominant in acute viral hepatitis.

Clinical Significance: In myocardial infarction LDH levels begins to raise 12 to 18 hours after onset of chest pain, reaches peak by 48 to 72hrs after episode and falls back to normally by 10 to 12 days [30,73,69]. Because of its prolonged half-life LDH-1 is a clinically sensitive (90%) marker for myocardial infarction when used after 24 hours of MI attack. In heart LDH is inhibited by pyruvate, so pyruvate cannot form lactate. Optimum interval for analysis for LDH isoenzyme is 48-72 hours period after the onset of chest pain. In normal healthy individual LDH-2 is more than LDH-1 in serum but in myocardial infarction LDH-1 isoenzyme increased more than LDH2 isoenzyme so there is reversal of ratio this is called flipped pattern (LDH-1/LDH-2 >1 in MI after 12-24 hours and the ratio remains >1 for seven days) which is present in more-than 80% of patients with myocardial infarction [74]. Diagnostic sensitivity of LDH estimation of myocardial infarction is around 90% and diagnostic specificity is 90 -99% [75]. Favorable response to therapy may be accompanied by fall in serum LDH enzyme and recurrence by rise in LDH. LDH-1 rises with in ten to twelve hours of myocardial infarction, peak values attained at 72-144 hours and return to normal in ten days, paralleling total LDH. While taking blood for LDH estimation, hemolysis is avoided as LDH level is 100-150times more inside the RBC than in plasma, so giving a false positive test [76].

Other Causes of Elevation of LDH Activity: Total LDH values are also moderately elevated in myocarditis, hepatic congestion with cardiac failure, and leukemia, sever shock, in pernicious anemia, anoxia, haemolysis. High values can occur in primary or secondary tumors of the liver and very high values are seen in liver necrosis following exposure to carbon tetrachloride. High values are also seen in megaloblastic and haemolytic anemic, in renal disease and in generalized carcinomatosis, Hodgkin’s disease, lung cancer, germ cell tumours. Increase in CSF LDH activity has been reported in the presence of tumor of CNS.

Isoenzymes: Isoenzymes or isozymes are the multiple forms of an enzyme catalyzing the same reaction. Isoenzymes are physically distinct forms of the same enzyme. They thus catalyses the same chemical reaction, but differ from each other structurally, electrophoretically, immunologically, in catalytic activity. Synthesis of each is under its own genetic control. The pattern of isoenzymes found in the plasma may serve as a way of identifying the site of tissue damage e.g. Creatine kinase and LDH are often used in the diagnosis of myocardial infarction.

Lactate dehydrogenase (LDH) isoenzymes differ from one another at the level of the quaternary structure. The re-action proceeds at a measurable rate only in the presence of enzyme catalyst LDH.

Cardiac muscle is richest in LDH-1 and LDH-2. In myocardial infarction total LDH activity is increased while H4 activity isoenzyme is increased 5 to 10 times more (Table 9). The magnitude of the peak value as well as the area under the graph will be roughly proportional to the size of the myocardial infarct. Therefore, study of isoenzymes of LDH is of greater importance in differential diagnosis. Spleen, lung, pancreas, lymph nodes, adrenal, leukocytes and thyroid are richest in LDH-3 and Kidney richest in LDH-2.

LDH - X has been found between LDH-3 and LDH-4 in mature Testis and in spermatogenesis. Tumors are richest in LDH-3, LDH-4, LDH-5. LDH-1 is associated with oxidative metabolism and LD5 with anaerobic glycolysis [77].

Distinguishing these Isoenzymes

Heat stability: LDH-1 has been shown to be more heat resist-ant.
Heat stability index: The ratio of the activity after heating at 600C for an hour to that of untreated serum.
Behavior towards inhibitors: Inhibition of serum LDH by potassium oxalate and urea [78].

Serum Alpha Hydroxybutyrate

Dehydrogenase: LD catalyses reversible reduction of other Alpha Keto acid besides Pyrucate. Alpha KetoButyrate dehydrogenase = 56-125 U/L at 25 ºC.
LD / HBD 1.18 - 1.6 normally
LD / HBD <1.18 Myocardial infarction
Alpha HBD activity is a more sensitive index of myocardial infarction, than LDH and frequently elevated for a long time.

Aspartate Aminotransferase (A.S.T) (E.C.2.6.1.1): Formerly called serum glutamate oxaloacetate transaminase (SGOT). The systemic name is Aspartate oxoglutarate amino transferase (AST). Aminotransferases are enzymes, which catalyses the transfer of amino groups from alpha amino acids to a ketoacid to form the new amino acid and new ketoacid. Transamination reactions are reversible reactions. Pyridoxal 5-phosphate is a versatile coenzyme that participate in transamination reaction. Pyridoxal - 5-phosphate produce a marked increase in enzyme activity. Since oxaloacetate cannot pass through the inner membrane, it is converted by transamination to Aspartate that can move across the membrane. The two aminotransferase enzymes are

1. A.S.T --- Aspartate Aminotransferase.
2. A.L.T ---- Alanine Aminotransferase.

Aspartate aminotransferase (AST): The term transaminase is accepted as an alternative to amino transferase by the Enzyme Commission. It is predominantly present in myocardium and its levels are high in serum when there is myocardial damage due to infarction. Aspartate aminotransferase catalyses transfer of amino group from L-aspartate to alpha ketoglutarate producing Oxaloacetate and L- glutamate.

The reaction is reversible and equilibrium favours formation of Aspartate. AST is found both in cytosol and mitochondria.

Distribution in Human Tissues: AST is widely distributed in animal tissue. Aspartate aminotransferase is present in human plasma, bile, CSF and saliva but not in urine.

Clinical Significance: In acute myocardial infarction serum levels of AST are found to be increased. On the average serum levels starts to rise 6 to 8 hours after onset of infarction and peak values are reached after 18 to 24 hours and values fall to normal range by 4th or 5th day provided no new infarct has occurred [25,59,61,62].

Abnormal aspartate aminotransferase levels are observed in more than 97% of cases of myocardial infarction when correctly timed blood specimens are analyzed. Average increases are 4 to 5 times the upper limit of normal are observed. Alanine aminotransferase (ALT) are normal in myocardial infarction. Peak value of aspartate aminotransferase activity is roughly proportional to the extent of damage [69]. AST content in myocardial cells is 10,000 times and in liver cells 5,000 times more than the serum value. Therefore AST level in serum is highly elevated in myocardial infarction and mildly elevated in liver disease. AST more than 350U/L is fatal, whereas AST >150U/L is associated with high mortality whereas AST <50 U/L is associated with low mortality [60].

Summary

Myocardial infarction is now becoming more common in our country. Hence it has become important to achieve early diagnosis in these patients to assess the effectiveness of treatment which is being given. This is achieved by serial estimations of Enzymes in patients Serum.

This study is done in patients who came to hospital within 1-2 hours after onset of chest pain and diagnosed as acute myocardial infarction with help of E.C.G. findings.

In the present study 20 cases of normal subjects and 25 cases of myocardial infarction cases are compared and found that the CK & CK-MB were increased in the 1st day of attack and their decrease was noticed on 3rd day. This shows that the estimation of CK & CK-MB are the earliest diagnostic tools for the diagnosis of myocardial infarction.

The estimation of total LDH, LDH-1 and LDH-2 were made and noticed that the total LDH and LDH-1 and LDH-2 showed peak levels starting from 3rd day to 6th day of the myocardial infarction attacks. This study confirms the diagnostic and therapeutic evaluation of the myocardial infarction cases.

The estimations of AST in 25 disease cases of myocardial infarction are done and the elevation of this enzyme is noticed from the 3rd day onwards and its decline was noticed on 6th day. This enzyme estimation will clearly indicate the progress of the myocardial infarction cases.

In 80% of the myocardial infarction cases the lipoprotein pattern increase is noticed. This clearly shows that total lipoprotein are the predisposing factors for the myocardial infarction.

Especially LDL is markedly increased in acute cases of myocardial infarction. HDL decrease is also noticed in 50 to 75% of myocardial infarction cases (Table 10).

In 80% of the acute myocardial infarction cases the increase of total serum cholesterol level was noticed. This estimation also shows that cholesterol is also one of the risk factor for myocardial infarction.

Myocardial infarction has become a major public health problem all over the word. The enzyme estimation of greatest change depends on the time interval after the suspected infarct. Enzyme elevations are present in about 95% cases of myocardial infarction and may reach very high level. A second rise in enzyme level after their return to normal indicate extension of infarction or development coronary heart failure, when CK do not rise. Rate of appearance of an enzyme in the circulation appear to depend on the rate and reperfusion of damaged myocardium and on size of enzyme molecule. Magnitude of peak value will be roughly proportional to the size of myocardial infarction. Study of isoenzyme LDH is of greatest importance in differential diagnosis. CK-MB values are very useful to detect early cases. Peak values of AST are roughly proportional to the extent of cardiac damage.

The extent of elevation to total CK and CK-MB on the 1st day of attack will indicate the severity of the attack. Serum total LDH and LDH-1 and LDH-2 levels are elevated from the 3rd day onwards. Normally LDH-2 is more than LDH-1 where as in cases of myocardial infarction LDH1 increase is clearly seen from our cases. These alteration of isoenzymes is called flipped pattern. These pattern is clearly seen in cases of myocardial infarction.

Sharp rise of AST was noticed from 3rd day onwards and decrease is seen 6th day. The elevated values of AST on 3rd day will indicate the attack of myocardial infarction.

Hypercholesterolemia is noticed in 90% of cases of myocardial infarction. Hypertriacylglyceridemia is also noted. There is a rise of LDL cholesterol in all the cases of myocardial infarction, whereas HDL-C levels are decreased in all the cases of myocardial infarction. So, the elevation of total cholesterol levels, Triacylglycerol, LDL-cholesterol, VLDL- cholesterol are the important risk factors for the attack of myocardial infarction.

Hence, we conclude that the serial estimations of serum enzymes like total CK, CK-MB, total LDH, LDH-1, LDH-2 and serum AST are increased in myocardial infarction cases and also helpful in achieving diagnosis, in the assessment of therapy being given and to predict the prognosis of acute myocardial infarction cases.

Acknowledgements

It gives me great pleasure to take this opportunity to thank everyone who have helped me during the course of my study and preparing the dissertation. It gives me immense pleasure to express my deep sense of gratitude and sincere thanks to Dr. M. Siva Reddy, MD., Professor and HOD of Biochemistry, for all his guidance, inspiration, moral support and encouragement throughout my post graduate course of dissertation.

I am highly indebted to Dr. U. Jaya Rami Reddy, MD., Professor of Biochemistry for his able guidance, encouragement and constructive criticism during the course of my study and during the preparation of this dissertation.

I wish to express my sincere thanks to Dr. KS. Thirumala Chari, MD., Principal, Kurnool Medical College, Kurnool for giving me this opportunity and also for being constant source of inspiration.

I would like to thank Dr. Sudha Kar, MD., Assistant professor of Biochemistry for valuable suggestions, encouragement and guidance during the course of study and the preparation of dissertation.

I owe a lot to Dr. T. Rama Krishna Reddy, M.D., (D.M) retired Principal, Professor and HOD of Cardiology for constant encouragement, support and valuable guidance and for his cooperation during this study.

I thank Dr. P. Chandra Sekhar, MD, DM., Assistant professor of Cardiology for his cooperation during this study.

I extend my thanks to Dr. Rama Mani, MD, tutor in Biochemistry for her valuable guidance and encouragement. My thanks to all my friends and colleagues for their cooperation and to all those patients who were part of the study.

I thank all the staff members of the department for their cooperation during my study.

2 Litvack F, Grundfest WS, Lee ME, Carroll RM, Foran R, et al. (1985) Angioscopic visualization of blood vessel interior in animals and humans. Clinical Cardiolo 8: 65-70.
6 Armstrong A, Duncan B, Oliver MF, Julian DG, Donald KW, et al. (1972) Natural history of acute coronary heart attacks. A community study. Br Heart J 34: 67.
16 Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, et al. (1991)Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324: 1149-55.
21 Epstein FH: Precocious heart disease Symposium, V world congress of cardiology, New Delhi, 1966.
28 Voet, D, & Voet, JG (2011). Biochemistry (4th ed.). Hoboken, NJ: Wiley.
32Murray R, Mayes PA, Rodwell, VW, Granner DK (2000) Murray R, Mayes PA, Rodwell, VW, Granner DK (2000)
38 Lung (1974) American Journal of Clinical Pathology 67
46 Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL (1972) Indices of relative weight and obesity. J Chronic Dis 25: 329-43.
47 Suchita P Dandekar (2009) Medical Biochemistry, 1st (edn).
53 Pasternac RC (1965) Acute myocardial infarction. Clin Pathol 38: 231-6
64 Tenanant R (1935) Effect of coronary occlusion on MI. A M J Physiol 112: 351.
65 Tietz W, Carl A Burtis, Edward R Ashwood (1994) Text book of clinical chemistry, 2nd edn.
66Virchow R (1856) Phalogose undethrombose is gefos system. 0458.

Clinical and Experimental Research in Cardiology

Tables at a glance
table-icon
Table 1
table-icon
Table 2
table-icon
Table 3
table-icon
Table 4
table-icon
Table 5
table-icon
Table 6
table-icon
Table 7
table-icon
Table 8
table-icon
Table 9
table-icon
Table 10
table-icon
Table 11

S.No

CK

CK-MB

LDH

LDH-1

LDH-2

AST

1

32.2

1.3

263

63.7

28

92

2

29.6

1.2

160

43.2

24

56

3

66.5

2

315

85

43.5

110.3

4

52.8

1.6

225

60.8

34.1

78.8

5

100.3

3

203

54.8

32

71

6

69.9

2.1

231.9

62.6

31.1

81.2

7

125

3.8

241

65

35

84.4

8

203

6

223.7

60.4

36.4

78.3

9

225

6.8

280.9

51.8

51.8

98.3

10

43

1.3

191.9

90.8

28.3

67.2

11

163

4.9

324.6

58.3

33.1

113.6

12

163

4.9

208.3

55

31.5

72.9

13

169

5

196.7

86.7

25

68.8

14

198

5.9

309.8

92.1

23.5

115.2

15

200

6

329

60.8

34.3

78.8

16

205

6.2

225

114.2

28

148

17

192

5.8

423

61.6

55.9

77

18

200

6

329.6

71.4

25

89.3

19

103

3.1

219.9

55

32

56

20

154

4.6

255

65

30.6

71

SD

70.3

2.5

82.5

17.6

10.9

4.4

MEAN

134.7

3

257.8

70.2

33.2

90.2

Table 1: Serial serum enzyme estimations in controls (Units per Litre)

S.NO

T.CHOL

HDL.C

TG

LDL.C

VLDL.C

1

162

54

128

82.4

25.6

2

183

60

104

102.2

20.8

3

226

65

132

134.6

26.4

4

242

72

147

140.6

29.4

5

180

68

104

91.2

20.8

6

214

80

152.7

103.6

30.54

7

160

32

128

102.4

25.6

8

267

53

147

184.6

29.4

9

168

32

134

109.2

26.8

10

194

39

128.6

129.28

25.72

11

243

42

147

171.6

29.4

12

210

58

152.7

121.46

30.54

13

200

40

128.6

134.28

25.72

14

280

48

147

202.6

29.4

15

175

26

101

128

20.2

16

220

28

144.8

163.04

28.96

17

215

53

98.4

142.32

19.68

18

163

62

134

74.2

26.8

19

192

64

128.6

128.28

25.72

20

235

38

144.8

168.04

28.96

SD

34.8

15.43

17.49

38.44

3.5

MEAN

206

50.7

131.6

130.73

26.32

Table 2: Lipid profile in controls (mg/dl)

S.NO

1st DAY

3rd DAY

1

250

220.3

2

480

175

3

398

283.9

4

1795

45.68

5

330

283.5

6

2761

819

7

2341

760

8

1916

294

9

591

190.7

10

475

175.8

11

385.8

205.8

12

2770

174

13

547.2

178

14

477.4

188

15

487.8

376.2

16

517.7

120

17

646.7

178

18

800.5

296.4

19

930.5

180

20

320.2

182

21

936

185

22

2233

240

23

1040

176

24

1540

182

25

1542

203

SD

806.15

159

MEAN

1060.5

252.5

Table 3: Serial serum enzyme estimations of CK in patients with AMI

Non Modifiable

Modifiable

Age

Smoking, Obesity

Male Sex

Hypertension Sedentary Lifestyle

Family History

Hyperlipidemia, Diabetes Mellitus

SNO

3rd DAY

6th DAY

1

128

30

2

76

25

3

75

22.2

4

56

26.3

5

120

26.3

6

23.76

84

7

230.9

51.44

8

92

28

9

482.6

30

10

165.53

37.53

11

60.11

30

12

94

28

13

154

24

14

68.18

26

15

51.8

24

16

122

25

17

74

34

18

34.82

25

19

125.5

25

20

136.8

30

21

53.3

28

22

82

34.12

23

157

28

24

80.6

26

25

82.3

29

SD

116.5

12.55

MEAN

113.1

31.02

Table 4: CK-MB levels in 3rd and 6th days of AMI

SNO

T-CHOL

HDL-C

TG

LDL-C

VLDL-C

1

275

25

160

218

32

2

260

29

180

195

36

3

286

32

164

221.2

32.8

4

380

25

320

291

64

5

286

29

180

221

36

6

274

28

160

214

32

7

314

28

200

246

40

8

315

20

200

255

40

9

308

25

185

246

37

10

275

32

160

211

32

11

288

37

164

218.2

32.8

12

276

32

160

212

32

13

266

34

180

196

36

14

154

42

272

57.6

54.4

15

300

25

150

245

30

16

265

40

180

189

36

17

282

30

156

220.8

31.2

18

275

29

160

214

32

19

326

33

188

255.4

37.6

20

265

24

180

205

36

21

356

20

396

256.8

79.2

22

320

35

200

245

40

23

300

25

150

245

30

24

310

26

200

244

40

25

300

25

150

245

30

SD

55.95

5.69

57.82

45.39

22.63

MEAN

252.4

28.12

183.8

205.55

41.48

Table 5: Lipid profile in cases of AMI

ENZYMES

START TO RISE

PEAK EVALUATION

DURAION OF RISE

CK

4 to 8 hrs

24 to 48 hrs

3 to 5 days

AST

6 to 12 hrs

24 to 48 hrs

4 to 6 days

LDH

24 to 48 hrs

72 to 146 hrs

8 to 14 days

Table 6: Enzymes and AMI

CHAIN

MOBILITY

OF ORIGIN

CK-1     BB

MAXIMUM

BRAIN          01%

CK-2     MB

INTERMEDIATE

HEART         09%

CK-3     MM

LEAST

SKELETAL     -

Table 7: Type polypeptide electrophoretic tissue percentage in blood

1.

LDH

(H H H H)

H4.

Heart and RBC

25-45%

3.

LDH3

(H H M M)

H2 M2.

Pancreas, brain

20-40%

2.

LDH2

(H H H M)

H3 M.

Heart and RBC, Kidney

10-25%

4.

LDH4

(H M M M)

H M3.

Liver, skeletal muscle

0-12%

5.

LDH5

(M M M M)

M4.

Skeletal muscle and liver

0-12%

Table 8: Isoenzyme subunit site percentage

S.NO

3rd DAY

6th DAY

1

618.4

428

2

620

480

3

678.1

478

4

975

625.4

5

585

530

6

1853

1509

7

1544

1041

8

720

600

9

1874

1574

10

800

585

11

1127

780

12

526

400

13

1240

925

14

520

450

15

480.9

380

16

422

400

17

378

325

18

938.8

570.6

19

546

440

20

752.6

620

21

669

440

22

1116

500

23

543

420

24

885.4

500

25

418

302

SD

421.42

326.53

MEAN

833.2

612.12

Table 9: Serial serum enzyme estimations of LDH in patients with AMI


S.NO

INVESTIGATION

VALUES

CONTROLS

MI

 

 

 

SUBJECTS

SUBJECTS

1

Total cholesterol

Mean

206

252.4

 

 

SD

34.8

55.95

2

Triacylglycerol

Mean

131.6

183.8

 

 

SD

17.49

57.85

3

HDL cholesterol

Mean

50.7

28.12

 

 

SD

15.43

5.69

4

LDL cholesterol

Mean

130.73

205.55

 

 

SD

38.44

45.39

5

VLDL cholesterol

Mean

26.32

41.48

 

 

SD

3.5

22.63

Table 10: Comparative statistical analysis of the enzyme / Estimations in AMI patients and in controls

Partnered Content Networks

  • Cancer Science
  • Vaccine Studies
  • Gynecology
  • Food Nutrition
  • Nursing Science
  • Public Health
  • The Pharma
  • Infectious Disease
  • Neuro Care
  • Catalysis
  • Neonatal Biology
  • Neonatal Disorders
  • Mutation
  • Nanotechnology
  • Toxicology
  • Dark Biotechnology
  • Pollution Toxicology
  • Cell Biology
  • Bioanalytical Research
  • Renal Disorders
  • The Astrophysics
  • Sleep Physiology
  • Epidemiology
  • Histology